2014 ESC/EACTS Guidelines on myocardial revascularization

The complete list of references is available in the online version of this paper at: http://ejcts.oxfordjournals.org/.

1999, European system for cardiac operative risk evaluation (EuroSCORE), Eur J Cardiothorac Surg, 16, 9, 10.1016/S1010-7940(99)00134-7

2003, The logistic EuroSCORE, Eur Heart J, 24, 881

2012, EuroSCORE II, Eur J Cardiothorac Surg, 41, 734, 10.1093/ejcts/ezs043

2009, The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1: coronary artery bypass grafting surgery, Ann Thorac Surg, 88, S2

2013, Coronary artery bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial, Lancet, 381, 629, 10.1016/S0140-6736(13)60141-5

2012, Combined anatomical and clinical factors for the long-term risk stratication of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score, Eur Heart J, 33, 3098, 10.1093/eurheartj/ehs295

2013, Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II, Lancet, 381, 639, 10.1016/S0140-6736(13)60108-7

2012, Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study), Circulation, 125, 1491, 10.1161/CIRCULATIONAHA.111.066902

2012, Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry, Circulation, 125, 1501, 10.1161/CIRCULATIONAHA.111.066969

2005, The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 1, 219

2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med, 360, 213, 10.1056/NEJMoa0807611

2012, Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease, N Engl J Med, 367, 991, 10.1056/NEJMoa1205361

2002, Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis, J Am Coll Cardiol, 39, 1151, 10.1016/S0735-1097(02)01726-6

2008, Diagnostic performance of coronary angiography by 64-row CT, N Engl J Med, 359, 2324, 10.1056/NEJMoa0806576

2009, On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography, JACC Cardiovasc Interv, 2, 550, 10.1016/j.jcin.2009.03.009

2006, A comparative regional analysis of coronary atherosclerosis and calcium score on multi-slice CT versus myocardial perfusion on SPECT, J Nucl Med, 47, 1749

2001, Exercise echocardiography for the prognostic stratication of patients with low pretest probability of coronary artery disease, Am J Med, 111, 18, 10.1016/S0002-9343(01)00746-X

2004, Prognostic value of exercise echocardiography in patients with classic angina pectoris, Am J Cardiol, 94, 559, 10.1016/j.amjcard.2004.05.016

Echo Persantine International Cooperative Study G. Echo Dobutamine International Cooperative Study G, 2003, Stress echo results predict mortality: a large-scale multicenter prospective international study, J Am Coll Cardiol, 41, 589, 10.1016/S0735-1097(02)02863-2

2012, Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis, J Am Coll Cardiol, 60, 1828, 10.1016/j.jacc.2012.07.038

2003, Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients, J Nucl Med, 44, 134

2012, Diagnostic accuracy of cardiac positron emission tomography vs. single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis, Circ Cardiovasc Imaging, 5, 700, 10.1161/CIRCIMAGING.112.978270

2007, Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis, J Am Coll Cardiol, 50, 1343, 10.1016/j.jacc.2007.06.030

2008, MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial, Eur Heart J, 29, 480, 10.1093/eurheartj/ehm617

2012, Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus, Circulation, 126, 1858, 10.1161/CIRCULATIONAHA.112.120402

2010, Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally signicant coronary artery disease, Circulation, 122, 603, 10.1161/CIRCULATIONAHA.109.915009

2013, Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions, Heart, 99, 188, 10.1136/heartjnl-2012-302761

2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829

2009, A randomized trial of therapies for type 2 diabetes and coronary artery disease, N Engl J Med, 360, 2503, 10.1056/NEJMoa0805796

2010, Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease, Circulation, 122, 949, 10.1161/CIRCULATIONAHA.109.911669

2011, Impact of ischaemia and scar on the therapeutic benet derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy, Eur Heart J, 32, 1012, 10.1093/eurheartj/ehq500

2013, Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease, Circulation, 127, 769, 10.1161/CIRCULATIONAHA.112.131961

2009, Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials, Lancet, 373, 1190, 10.1016/S0140-6736(09)60552-3

1994, Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, Lancet, 344, 563, 10.1016/S0140-6736(94)91963-1

2011, Coronary-artery bypass surgery in patients with left ventricular dysfunction, N Engl J Med, 364, 1607, 10.1056/NEJMoa1100356

2008, A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease, J Am Coll Cardiol, 52, 894, 10.1016/j.jacc.2008.05.051

2012, Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York, Circulation, 125, 1870, 10.1161/CIRCULATIONAHA.111.071811

2012, Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials, Circulation, 125, 2873, 10.1161/CIRCULATIONAHA.112.097014

2012, Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials, Eur Heart J, 33, 1214, 10.1093/eurheartj/ehs086

2013, Safety and efcacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials, Lancet, 382, 1879, 10.1016/S0140-6736(13)61782-1

2013, Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis, BMJ, 347, f6625, 10.1136/bmj.f6625

2010, Drug-eluting versus bare-metal stents in large coronary arteries, N Engl J Med, 363, 2310, 10.1056/NEJMoa1009406

2013, Bayesian methods afrm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease, Circulation, 127, 2177, 10.1161/CIRCULATIONAHA.112.000646

2009, The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction, Circulation, 120, 2529, 10.1161/CIRCULATIONAHA.109.913111

2003, Comparison of the short-term survival benet associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography, Circulation, 107, 2900, 10.1161/01.CIR.0000072790.23090.41

1997, Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization, Circulation, 95, 2037, 10.1161/01.CIR.95.8.2037

2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626

2008, Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery, JACC Cardiovasc Interv, 1, 483, 10.1016/j.jcin.2008.07.001

1986, Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events, N Engl J Med, 314, 1, 10.1056/NEJM198601023140101

2010, Thirty-year follow-up denes survival benet for second internal mammary artery in propensity-matched groups, Ann Thorac Surg, 90, 101, 10.1016/j.athoracsur.2010.04.006

2011, Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data, J Am Coll Cardiol, 58, 1426, 10.1016/j.jacc.2011.07.005

2012, Strategies for multivessel revascularization in patients with diabetes, N Engl J Med, 367, 2375, 10.1056/NEJMoa1211585

2013, Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial, JACC Cardiovasc Interv, 6, 20, 10.1016/j.jcin.2012.09.008

2011, ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, 32, 2999, 10.1093/eurheartj/ehr236

2011, Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes, Eur Heart J, 32, 32, 10.1093/eurheartj/ehq276

2009, Safety and efcacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies, Circulation, 119, 3198, 10.1161/CIRCULATIONAHA.108.826479

2005, Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial, J Am Coll Cardiol, 45, 1165, 10.1016/j.jacc.2004.10.074

2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215

1996, Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, 348, 771, 10.1016/S0140-6736(96)02514-7

2006, Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials, Lancet, 367, 579, 10.1016/S0140-6736(06)68148-8

2013, Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction, N Engl J Med, 368, 1379, 10.1056/NEJMoa1301092

2003, Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis, Circulation, 108, 1809, 10.1161/01.CIR.0000091088.63921.8C

1999, Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock, N Engl J Med, 341, 625, 10.1056/NEJM199908263410901

2007, A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction, Circulation, 116, 721, 10.1161/CIRCULATIONAHA.107.694141

2007, Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications, Circulation, 116, e68, 10.1161/CIRCULATIONAHA.107.184052

2006, Strategies for reducing the door-to-balloon time in acute myocardial infarction, N Engl J Med, 355, 2308, 10.1056/NEJMsa063117

2004, Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials, Am J Med, 116, 253, 10.1016/j.amjmed.2003.08.035

2012, Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial, Lancet, 380, 1482, 10.1016/S0140-6736(12)61223-9

2012, Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial, JAMA, 308, 777, 10.1001/jama.2012.10065

2013, A meta-analytic overview of thrombectomy during primary angioplasty, Int J Cardiol, 166, 606, 10.1016/j.ijcard.2011.11.102

2013, Thrombus aspiration during ST-segment elevation myocardial infarction, N Engl J Med, 369, 1587, 10.1056/NEJMoa1308789

2011, Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis, J Am Coll Cardiol, 58, 692, 10.1016/j.jacc.2011.03.046

2013, Randomized trial of preventive angioplasty in myocardial infarction, N Engl J Med, 369, 1115, 10.1056/NEJMoa1305520

2009, Routine early angioplasty after brinolysis for acute myocardial infarction, N Engl J Med, 360, 2705, 10.1056/NEJMoa0808276

2010, Early routine percutaneous coronary intervention after brinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis, Eur Heart J, 31, 2156, 10.1093/eurheartj/ehq204

2005, Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction, N Engl J Med, 353, 2758, 10.1056/NEJMoa050849

2001, One-year survival following early revascularization for cardiogenic shock, JAMA, 285, 190, 10.1001/jama.285.2.190

1994, Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction, Circulation, 90, 2280, 10.1161/01.CIR.90.5.2280

2009, Coronary bypass surgery with or without surgical ventricular reconstruction, N Engl J Med, 360, 1705, 10.1056/NEJMoa0900559

2013, Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction, J Thorac Cardiovasc Surg, 146, 1139, 10.1016/j.jtcvs.2012.09.007

2006, Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction, JAMA, 295, 2511, 10.1001/jama.295.21.2511

2009, A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?, Eur Heart J, 30, 459

2008, Greater clinical benet of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38, Circulation, 118, 1626, 10.1161/CIRCULATIONAHA.108.791061

2012, An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials, J Am Coll Cardiol, 60, 106, 10.1016/j.jacc.2012.02.059

2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327

2013, Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial, Eur J Cardiothorac Surg, 43, 1006, 10.1093/ejcts/ezt017

2013, Comparison of coronary artery bypass surgery and percutaneous coronary interventions in patients with diabetes: a meta-analysis of randomised controlled trials, Lancet Diabetes Endocrinol, 1, 317, 10.1016/S2213-8587(13)70089-5

2012, Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials, BMJ, 345, e5170, 10.1136/bmj.e5170

2009, Early versus delayed, provisional eptibatide in acute coronary syndromes, N Engl J Med, 360, 2176, 10.1056/NEJMoa0901316

2007, Primary percutaneous coronary intervention compared with brinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial, Arch Intern Med, 167, 1353, 10.1001/archinte.167.13.1353

2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tiroban, N Engl J Med, 344, 1879, 10.1056/NEJM200106213442501

2012, Bilateral internal mammary artery grafting enhances survival in diabetic patients: a 30-year follow-up of propensity score-matched cohorts, Circulation, 126, 2935, 10.1161/CIRCULATIONAHA.112.117606

2011, Safety and efcacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database, J Am Coll Cardiol, 58, 1859, 10.1016/j.jacc.2011.06.056

2012, Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD, J Am Soc Nephrol, 23, 2042, 10.1681/ASN.2012060554

2008, Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial, JAMA, 300, 1038, 10.1001/jama.300.9.1038

2012, Efcacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials, PLoS One, 7, e34450, 10.1371/journal.pone.0034450

2010, Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry, Circulation, 121, 357, 10.1161/CIRCULATIONAHA.109.865352

2013, Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease, Eur J Cardiothorac Surg, 43, 459, 10.1093/ejcts/ezs360

2007, Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors, Ann Thorac Surg, 84, 1264, 10.1016/j.athoracsur.2007.05.016

2007, Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufciency: a randomized study, J Thorac Cardiovasc Surg, 133, 378, 10.1016/j.jtcvs.2006.09.028

2003, Nephrotoxic effects in high-risk patients undergoing angiography, N Engl J Med, 348, 491, 10.1056/NEJMoa021833

2014, Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome. Results from Protective effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS Study), J Am Coll Cardiol, 63, 71

2006, A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media, J Am Coll Cardiol, 48, 692, 10.1016/j.jacc.2006.02.073

2011, Renal Insufciency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury, Circulation, 124, 1260, 10.1161/CIRCULATIONAHA.111.030759

ACT-Investigators, 2011, Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT), Circulation, 124, 1250, 10.1161/CIRCULATIONAHA.111.038943

2003, The prevention of radiocontrast-agent-induced nephropathy by hemoltration, N Engl J Med, 349, 1333, 10.1056/NEJMoa023204

2012, Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial, Circulation, 125, 2639, 10.1161/CIRCULATIONAHA.111.072256

2012, Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: nal results of the Randomized Ischemic Mitral Evaluation (RIME) trial, Circulation, 126, 2502, 10.1161/CIRCULATIONAHA.112.143818

2009, Indications for carotid screening in patients with coronary artery disease, Presse Med, 38, 977, 10.1016/j.lpm.2009.02.015

2005, Carotid end-arterectomy: an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 65, 794, 10.1212/01.wnl.0000176036.07558.82

2011, Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting, J Thorac Cardiovasc Surg, 142, 1499, 10.1016/j.jtcvs.2011.04.031

2011, Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8 studies, J Thorac Cardiovasc Surg, 142, e11, 10.1016/j.jtcvs.2010.11.034

2010, Stenting versus endarterectomy for treatment of carotid-artery stenosis, N Engl J Med, 363, 11, 10.1056/NEJMoa0912321

2011, Carotid revascularization immediately before urgent cardiac surgery practice patterns associated with the choice of carotid artery stenting or endarterectomy: a report from the CARE (Carotid Artery Revascularization and Endarterectomy) registry, JACC Cardiovasc Interv, 4, 1200

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

2006, Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting, Cardiovasc Intervent Radiol, 29, 519, 10.1007/s00270-005-5288-y

2005, The benets of combined anti-platelet treatment in carotid artery stenting, Eur J Vasc Endovasc Surg, 29, 522, 10.1016/j.ejvs.2005.01.012

2009, Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study, J Am Coll Cardiol, 54, 989, 10.1016/j.jacc.2009.05.041

2013, Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation, J Am Coll Cardiol, 61, 302, 10.1016/j.jacc.2012.09.045

2002, Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts, Circulation, 105, 1285, 10.1161/01.CIR.0000012783.63093.0C

2003, Randomized comparison of distal protection with a lter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts, Circulation, 108, 548, 10.1161/01.CIR.0000080894.51311.0A

2011, Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial, Lancet, 378, 1071, 10.1016/S0140-6736(11)61255-5

2010, Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study, J Am Coll Cardiol, 55, 2710, 10.1016/j.jacc.2010.02.009

2013, Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial, Lancet, 381, 461, 10.1016/S0140-6736(12)61964-3

1997, Prophylactic use of implanted cardiac debrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) patch trial investigators, N Engl J Med, 337, 1569, 10.1056/NEJM199711273372201

2009, Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study, Eur Heart J, 30, 566, 10.1093/eurheartj/ehn529

2007, Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction, Circulation, 115, 1354, 10.1161/CIRCULATIONAHA.106.657619

2011, Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular brillation, Crit Care, 15, R122, 10.1186/cc10227

2003, Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study, Am Heart J, 145, 226, 10.1067/mhj.2003.147

2010, Pharmacologic prophylaxis for atrial brillation following cardiac surgery: a systematic review, J Cardiothorac Surg, 5, 121, 10.1186/1749-8090-5-121

2009, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial brillation: a randomised non-inferiority trial, Lancet, 374, 534, 10.1016/S0140-6736(09)61343-X

2006, Prophylactic amiodarone for prevention of atrial brillation after cardiac surgery: a meta-analysis, Ann Thorac Surg, 82, 1927, 10.1016/j.athoracsur.2006.06.032

2006, Incidence and outcome of atrial brillation in stable symptomatic coronary disease, Scand Cardiovasc J, 40, 152, 10.1080/14017430600746268

2006, Time dependence of debrillator benet after coronary revascularization in the Multicenter Automatic Debrillator Implantation Trial (MADIT)-II, J Am Coll Cardiol, 47, 1811, 10.1016/j.jacc.2005.12.048

2010, Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting, Ann Thorac Surg, 89, 403, 10.1016/j.athoracsur.2009.09.061

2009, Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage, Ann Thorac Surg, 87, 62, 10.1016/j.athoracsur.2008.08.049

2013, Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients, Ann Thorac Surg, 95, 862, 10.1016/j.athoracsur.2012.11.068

2013, Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: meta-analysis and meta-regression of 4817 patients, Interact CardioVasc Thorac Surg, 16, 849, 10.1093/icvts/ivt012

2013, Simple adaptations of surgical technique to critically reduce the risk of postoperative sternal complications in patients receiving bilateral internal thoracic arteries, Interact CardioVasc Thorac Surg, 17, 378, 10.1093/icvts/ivt089

2001, Skeletonized internal thoracic artery grafts and wound complications, J Thorac Cardiovasc Surg, 121, 625, 10.1067/mtc.2001.111654

2013, The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial, J Am Coll Cardiol, 61, 282, 10.1016/j.jacc.2012.10.017

2013, Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting, J Surg Res, 185, 166, 10.1016/j.jss.2013.05.042

2013, Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies, J Am Coll Cardiol, 62, 1421, 10.1016/j.jacc.2013.05.033

1994, Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up, J Thorac Cardiovasc Surg, 107, 657, 10.1016/S0022-5223(94)70320-5

2006, Influence of patient characteristics and arterial grafts on freedom from coronary reoperation, J Thorac Cardiovasc Surg, 131, 90, 10.1016/j.jtcvs.2005.05.024

2013, A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting, Ann Cardiothorac Surg, 2, 390

2010, Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial, J Thorac Cardiovasc Surg, 139, 60, 10.1016/j.jtcvs.2009.09.043

2012, Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index, J Thorac Cardiovasc Surg, 146, 1142

2009, Off-pump coronary artery bypass disproportionately benets high-risk patients, Ann Thorac Surg, 88, 1142, 10.1016/j.athoracsur.2009.04.135

2004, Procedural volume as a marker of quality for CABG surgery, JAMA, 291, 195, 10.1001/jama.291.2.195

1997, Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. K.U. Leuven Coronary Surgery Program, Eur J Cardiothorac Surg, 12, 1, 10.1016/S1010-7940(97)00134-6

2012, Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery, JAMA, 308, 475

2013, Endoscopic vein harvest for coronary artery bypass grafting is safe, J Surg Res, 185, 522, 10.1016/j.jss.2012.12.050

2010, Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft, Curr Opin Cardiol, 25, 609, 10.1097/HCO.0b013e32833f0498

2012, Bilateral internal mammary artery grafting enhances survival in diabetic patients: a 30-year follow-up of propensity score-matched cohorts, Circulation, 126, 2935, 10.1161/CIRCULATIONAHA.112.117606

2011, Outcomes associated with bilateral internal thoracic artery grafting: the importance of age, Ann Thorac Surg, 92, 1269, 10.1016/j.athoracsur.2011.05.083

2004, A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts, N Engl J Med, 351, 2302, 10.1056/NEJMoa040982

2013, Total arterial coronary revascularization-patient selection, stenoses, conduits, targets, Ann Cardiothorac Surg, 2, 499

2012, Clampless off-pump versus conventional coronary artery revascularization: a propensity score analysis of 788 patients, Circulation, 126, S176

2009, Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis, Circ Cardiovasc Interv, 2, 167, 10.1161/CIRCINTERVENTIONS.108.799494

2014, Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study, Circulation, 129, 463, 10.1161/CIRCULATIONAHA.113.003942

2013, Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results, J Am Coll Cardiol, 62, 30, 10.1016/j.jacc.2013.04.015

2011, A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial, J Am Coll Cardiol, 57, 914, 10.1016/j.jacc.2010.10.023

2011, Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus, Am J Cardiol, 108, 924, 10.1016/j.amjcard.2011.05.021

2012, Successful recanalization of chronic total occlusions is associated with improved long-term survival, JACC Cardiovasc Interv, 5, 380, 10.1016/j.jcin.2012.01.012

2004, Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions, J Am Coll Cardiol, 44, 967, 10.1016/j.jacc.2004.05.058

2011, Antiplatelet agents for the treatment and prevention of atherothrombosis, Eur Heart J, 32, 2922, 10.1093/eurheartj/ehr373

2012, Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis, JAMA, 308, 2507, 10.1001/jama.2012.50788

2011, for GI. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial, JAMA, 305, 1097, 10.1001/jama.2011.290

2008, Bivalirudin versus unfractionated heparin during percutaneous coronary intervention, N Engl J Med, 359, 688, 10.1056/NEJMoa0802944

2006, Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention, N Engl J Med, 355, 1006, 10.1056/NEJMoa052711

2012, Efcacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis, BMJ, 344

2006, A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial, J Am Coll Cardiol, 48, 931, 10.1016/j.jacc.2006.04.090

2008, Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8, Eur Heart J, 29, 1495, 10.1093/eurheartj/ehn169

2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1

2005, Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900 mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) trial, Circulation, 112, 2946, 10.1161/CIRCULATIONAHA.105.559088

2012, Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial, Circulation, 125, 2015, 10.1161/CIRCULATIONAHA.111.071589

1996, A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents, N Engl J Med, 334, 1084, 10.1056/NEJM199604253341702

2012, Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials, Eur Heart J, 33, 3078, 10.1093/eurheartj/ehs318

2013, Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial, JAMA, 310, 2510

2012, A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efcacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation), J Am Coll Cardiol, 60, 1340, 10.1016/j.jacc.2012.06.043

2010, ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention, Eur Heart J, 31, 2482, 10.1093/eurheartj/ehq330

2007, Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials, Arch Intern Med, 167, 2423, 10.1001/archinte.167.22.2423

2010, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, Lancet, 376, 1233, 10.1016/S0140-6736(10)61088-4

2006, Bivalirudin for patients with acute coronary syndromes, N Engl J Med, 355, 2203, 10.1056/NEJMoa062437

2011, Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction, N Engl J Med, 365, 1980, 10.1056/NEJMoa1109596

2004, Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial, JAMA, 292, 45

2010, Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis, Circulation, 122, 2131, 10.1161/CIRCULATIONAHA.109.927582

2013, the AI. Pretreatment with prasugrel in non-St-segment elevation acute coronary syndromes, N Engl J Med, 369, 999, 10.1056/NEJMoa1308075

2010, Low-dose versus standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial, JAMA, 304, 1339, 10.1001/jama.2010.1320

2009, investigators T-T. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, Lancet, 373, 723, 10.1016/S0140-6736(09)60441-4

2008, Ongoing Tiroban In Myocardial infarction Evaluation 2 study g. Prehospital initiation of tiroban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial, Lancet, 372, 537, 10.1016/S0140-6736(08)61235-0

2008, Bivalirudin during primary PCI in acute myocardial infarction, N Engl J Med, 358, 2218, 10.1056/NEJMoa0708191

2013, A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial), Am J Cardiol, 112, 1367, 10.1016/j.amjcard.2013.07.003

2011, Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, Eur Heart J, 32, 2989, 10.1093/eurheartj/ehr202

2011, Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction, Lancet, 378, 693, 10.1016/S0140-6736(11)60876-3

2012, the AACSTI. Rivaroxaban in patients with a recent acute coronary syndrome, N Engl J Med, 366, 9, 10.1056/NEJMoa1112277

2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1

2012, Bedside monitoring to adjust antiplatelet therapy for coronary stenting, N Engl J Med, 367, 2100, 10.1056/NEJMoa1209979

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

2010, Clopidogrel with or without omeprazole in coronary artery disease, N Engl J Med, 363, 1909, 10.1056/NEJMoa1007964

2012, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092

2010, Efcacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5

2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317

2003, Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review, JAMA, 290, 86, 10.1001/jama.290.1.86

2005, Meta-analysis: secondary prevention programs for patients with coronary artery disease, Ann Intern Med, 143, 659, 10.7326/0003-4819-143-9-200511010-00010

2009, When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal, J Hypertens, 27, 923, 10.1097/HJH.0b013e32832aa6b5

1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6

1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401

1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2

2005, Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), Eur Heart J, 26, 215, 10.1093/eurheartj/ehi115

2011, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492

2013, Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials, Eur Heart J, 34, 2263, 10.1093/eurheartj/eht101